The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 24, 2017
Filed:
Sep. 18, 2013
Applicant:
Ekr Therapeutics, Inc., Cary, NC (US);
Inventors:
Assignee:
EKR Therapeutics, Inc., Cedar Knolls, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/455 (2006.01); A61K 47/48 (2006.01); A61K 9/00 (2006.01); A61K 31/4422 (2006.01); A61K 47/10 (2006.01); A61K 47/12 (2006.01); A61K 47/14 (2006.01); A61K 47/26 (2006.01); A61K 47/40 (2006.01); C08B 37/16 (2006.01); C08L 5/16 (2006.01); B82Y 5/00 (2011.01);
U.S. Cl.
CPC ...
A61K 47/48969 (2013.01); A61K 9/0019 (2013.01); A61K 31/4422 (2013.01); A61K 31/455 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/14 (2013.01); A61K 47/26 (2013.01); A61K 47/40 (2013.01); B82Y 5/00 (2013.01); C08B 37/0015 (2013.01); C08L 5/16 (2013.01);
Abstract
Compositions of an inclusion complex of nicardipine or a pharmaceutically acceptable salt thereof and a sulfoalkylated β-cyclodextrin. The compositions being formulated for parenteral bolus administration to a human subject. The compositions being useful in the treatment of cardiovascular and cerebrovascular disorders.